Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Friday
May 24th
Home arrow Pharma Licensing arrow Pharma Out-Licensing
Pharma Out-Licensing
Olanzapine- mouth dissolving tablets Print E-mail

There is on-going development of generic EU CTD Dossier of Olanzapine, mouth dissolving tablets, 5/10/15/20 mg.

Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

Read more...
 
Oxcarbazepine Print E-mail
There is on-going development of generic EU CTD Dossier of Oxcarbazepine, filmcoated tablets, 150/300/600 mg.

Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

Read more...
 
Losartan potassium-hydrochlorothiazide Print E-mail
Member of Farmavita.Net offers generic EU CTD Dossier of Losartan potassium-hydrochlorothiazide, tablets, 50+12.5/100+25 mg.

Registration is going-on in refrence member state of EU.

Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

Read more...
 
Levofloxacin hemihydrate Print E-mail

There is on-going development of generic EU CTD Dossier of Levofloxacin hemihydrate, 250/500 mg, filmcoated tablets. 

Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

Read more...
 
Pantoprazole tablets Print E-mail
There is on-going development of generic EU CTD Dossier of Pantoprazole, 20/40 mg, Gastro-resistant tablets.

Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 46 - 54 of 326
Advertisement

Featured Partners

 
logo_kvadrat_150x150.jpg    
lcm-150x150.jpg  
150-150-static.gif
apacma13_150x150_banner.gif  
  doctors20150x1501.png
bals137_150x150.gif
bals138_150x150.jpg
ch-150x150-an.gif 
pharmaccess13a_150x150.gif 

Login to Farmavita.Net

membership is FREE

Follow us on:




Join our LinkedIn Group

BabelFish Translator




Click Flag for Translation

Who's Online

We have 13 guests online

Farmavita.Net RSS News


Reports

rbdl0002_innovations-in-inj.gif 

Events

150-150-static.gif

Reports

rbhc0264_privatehealthcare.gif 

REPORTS

farmavita_research-store.gif